Skip to content
healthcare.dev
Get a free key

Ultomiris

NDC 25682-025, ravulizumab, solution, concentrate, from Alexion Pharmaceuticals Inc..

Product NDC
25682-025
Status
Listed
Labeler
Alexion Pharmaceuticals Inc.
Dosage form
SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761108
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25682-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RAVULIZUMAB300 mg/3mL

Pharmacologic classes

Complement Inhibitor [EPC]; Complement Inhibitors [MoA]

Package NDCNDC-11Package
25682-025-01256820025011 VIAL, GLASS in 1 CARTON (25682-025-01) / 3 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a9a590d9-0217-43c7-908d-e62a71279791

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25682-025

Use it

Look up 25682-025 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25682-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25682-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.